Computational Methods for the Analysis and Prediction of EGFR-Mutated Lung Cancer Drug Resistance: Recent Advances in Drug Design, Challenges and Future Prospects
<p dir="ltr">Lung cancer is a major cause of cancer deaths worldwide, and has a very low survival rate. Non-small cell lung cancer (NSCLC) is the largest subset of lung cancers, which accounts for about 85% of all cases. It has been well established that a mutation in the epidermal g...
Saved in:
| Main Author: | Rizwan Qureshi (15279193) (author) |
|---|---|
| Other Authors: | Bin Zou (539731) (author), Tanvir Alam (638619) (author), Jia Wu (169990) (author), Victor H. F. Lee (10738845) (author), Hong Yan (27984) (author) |
| Published: |
2023
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Leptomeningeal Metastatic L858R <i>EGFR</i>-mutant Lung Cancer: Prompt Response to Osimertinib in the Absence of T790M-mutation and Effective Subsequent Pulsed Erlotinib
by: Aladdin Kanbour (14442123)
Published: (2022) -
Machine learning based personalized drug response prediction for lung cancer patients
by: Rizwan Qureshi (15279193)
Published: (2022) -
Identification of Novel MicroRNAs as Promising Therapeutics for SARS-CoV-2 by Regulating the EGFR-ADAM17 Axis: An In Silico Analysis
by: Mukhopadhyay, Debasmita
Published: (2021) -
Anti-cancer Evaluation of Lebanese Cannabis Oil Extract on Lung and Breast Cancer Cells
by: Saliba, Jane
Published: (2021) -
GSTP1 and NQO1 polymorphisms as risk indicators of lung cancer in Lebanon. (c2006)
by: Ahmarani, Lena Pierre
Published: (2006)